Moderna Inc (MRNA)

Milan


	Symbol		Exchange		Currency
	MRNA		NASDAQ		USD	Real-time
	MRNA		Mexico		MXN	Delayed
	MRNA		Milan		EUR	Real-time
	0QF		Frankfurt		EUR	Delayed
	0QF		TradeGate		EUR	Delayed
	0QF		Xetra		EUR	Delayed
	MRNAm		Buenos Aires		ARS	Delayed
	M1RN34		B3		BRL	Delayed
	MRNA		Vienna		EUR	Real-time
	MRNA_KZ		KASE		USD	Delayed
	MRNA		Lima		USD	Delayed

Currency in EUR

Disclaimer

53.71

+1.10(+2.09%)

Closed11/10

Fair Value

Day's Range

51.03

53.79

52 wk Range

51.03

157.28

MRNA Income Statement

Featured here, the Income Statement (earnings report) for Moderna Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

18,471

19,263

6,848

Total Revenues Growth

+2,200.25%

+4.29%

-64.45%

Cost Of Revenues

4,608

8,711

9,538

Gross Profit

13,863

10,552

-2,690

Gross Profit Growth

+2,510.96%

-23.88%

-125.49%

Gross Profit Margin %

75.05%

54.78%

-39.28%

Other Operating Expenses, Total

567

1,132

1,549

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+201.6%	+99.65%	+36.84%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	567	1,132	1,549
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-

Operating Income

13,296

9,420

-4,239

Operating Income Growth

+1,842.6%

-29.15%

-145%

EBIT Margin %

71.98%

48.9%

-61.9%

Net Interest Expenses

1

171

383

Net Interest Expenses Growth

-93.33%

+17,000%

+123.98%

Interest Expense, Total

-17

-29

-38

Interest And Investment Income

18

200

421

Other Non Operating Expenses, Total

-12

4

-14

EBT, Excl. Unusual Items

13,285

9,595

-3,870

Gain (Loss) On Sale Of Assets

-

-

-

Other Unusual Items, Total

-

-

-

EBT, Incl. Unusual Items

13,285

9,575

-3,942

EBT, Incl. Unusual Items Growth

+1,885.62%

-27.93%

-141.17%

EBT, Incl. Unusual Items Margin

71.92%

49.71%

-57.56%

Income Tax Expense

1,083

1,213

772

Net Income to Company

12,202

8,362

-4,714

Minority Interest

-

-

-

Net Income

12,202

8,362

-4,714

Net Income Growth

+1,733.47%

-31.47%

-156.37%

Net Income Margin %

66.06%

43.41%

-68.84%

Preferred Dividend and Other Adjustments

-

-

-

Net Income to Common Excl. Extra Items

12,202

8,362

-4,714

Basic EPS - Continuing Operations

30.28

21.22

-12.34

Basic EPS - Continuing Operations Growth

+1,644.3%

-29.9%

-158.14%

Diluted EPS - Continuing Operations

28.29

20.12

-12.34

Diluted EPS - Continuing Operations Growth

+1,542.9%

-28.88%

-161.33%

Basic Weighted Average Shares Outstanding

403

394

382

Diluted Weighted Average Shares Outstanding

431

416

382

Dividend Per Share

-

-

-

Dividend Per Share Growth

-

-

-

EBITDA

13,528

9,768

-3,618

EBITDA Growth

+1,948.09%

-27.79%

-137.04%

EBITDA Margin %

73.24%

50.71%

-52.83%

EBIT